Exportar Publicação

Sousa, C., Rigueiro-Neves, M., Passos, A. M., Ferreira, A. I. & Sá, M. J. (2021). Assessment of cognitive functions in patients with multiple sclerosis applying the normative values of the Rao’s brief repeatable battery in the Portuguese population. BMC Neurology. 21

C. Sousa et al.,  "Assessment of cognitive functions in patients with multiple sclerosis applying the normative values of the Rao’s brief repeatable battery in the Portuguese population", in BMC Neurology, vol. 21, 2021

@article{sousa2021_1731964994243,
	author = "Sousa, C. and Rigueiro-Neves, M. and Passos, A. M. and Ferreira, A. I. and Sá, M. J.",
	title = "Assessment of cognitive functions in patients with multiple sclerosis applying the normative values of the Rao’s brief repeatable battery in the Portuguese population",
	journal = "BMC Neurology",
	year = "2021",
	volume = "21",
	number = "",
	doi = "10.1186/s12883-021-02193-w",
	url = "https://bmcneurol.biomedcentral.com/about"
}

TY  - JOUR
TI  - Assessment of cognitive functions in patients with multiple sclerosis applying the normative values of the Rao’s brief repeatable battery in the Portuguese population
T2  - BMC Neurology
VL  - 21
AU  - Sousa, C.
AU  - Rigueiro-Neves, M.
AU  - Passos, A. M.
AU  - Ferreira, A. I.
AU  - Sá, M. J.
PY  - 2021
SN  - 1471-2377
DO  - 10.1186/s12883-021-02193-w
UR  - https://bmcneurol.biomedcentral.com/about
AB  - Background: The Brief Repeatable Battery of Neuropsychological Tests (BRBN-T) is one of the most sensitive and
used measures for detecting cognitive impairment in Multiple Sclerosis (MS).
Objective: The aim of this study was to adapt and validate this battery to the Portuguese population of MS
patients.
Methods: The Portuguese version of the BRBN-T was applied to a stratified control national sample of 326
individuals considering sex, age, educational level and geographic location and also a clinical sample of 115 MS
patients from several national hospitals. Through the exploration of its psychometrics properties, the Portuguese
BRBN-T norms were produced.
Results: The normative data is presented as a regression-based formula to adjust test scores for gender, education
and age, and the results reveal the BRBN-T has the ability to differentiate between MS patients and healthy
participant’s cognitive performance.
Conclusion: This study demonstrated in our clinical population a good ability to detect cognitive impairment. Its
clearly contributed to reinforcing the neuropsychological assessment in Portugal in patients with MS, by providing
a new set of instruments, which can be used in the clinical practice, and in future studies. Moreover, it will allow a
rigorous and precise support in relation to neuropsychological assessment for future longitudinal studies and
clinical trials.
ER  -